Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)
Phase 1/2 Completed
272 enrolled
A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)
Phase 1/2 Completed
214 enrolled
JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer
Phase 1/2 Completed
119 enrolled
A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors
Phase 1/2 Completed
68 enrolled 27 charts
A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer
Phase 1/2 Completed
64 enrolled 20 charts
Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects
Phase 1/2 Completed
83 enrolled 14 charts
Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer
Phase 1/2 Completed
41 enrolled
CANFOUR
Phase 1/2 Completed
167 enrolled
ImmunoSarc
Phase 1/2 Completed
197 enrolled
Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer
Phase 1/2 Completed
9 enrolled
B-MAD Chemotherapy in Newly-diagnosed Extranodal NK/ T-cell Lymphoma
Phase 1/2 Completed
34 enrolled
A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation
Phase 1/2 Completed
93 enrolled 24 charts
M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC)
Phase 1/2 Completed
70 enrolled 17 charts
MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 1/2 Completed
12 enrolled
Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer
Phase 1/2 Completed
47 enrolled 22 charts
A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors
Phase 1/2 Completed
40 enrolled
A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects
Phase 1/2 Completed
153 enrolled
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer
Phase 1/2 Completed
156 enrolled 13 charts
AA NABPLAGEM
Phase 1/2 Completed
27 enrolled
Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 1/2 Completed
156 enrolled 14 charts
PIVOT-02
Phase 1/2 Completed
557 enrolled 22 charts
PRV111
Phase 1/2 Completed
10 enrolled 13 charts
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Phase 1/2 Completed
70 enrolled 17 charts
A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma
Phase 1/2 Completed
28 enrolled 23 charts
Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma
Phase 1/2 Completed
127 enrolled
Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)
Phase 1/2 Completed
69 enrolled 9 charts
Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery
Phase 1/2 Completed
34 enrolled 9 charts
A Study of Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma
Phase 1/2 Completed
9 enrolled 11 charts
PI-CaP
Phase 1/2 Completed
105 enrolled
Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer
Phase 1/2 Completed
37 enrolled 9 charts
Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
Phase 1/2 Completed
55 enrolled 11 charts
NOA-07
Phase 1/2 Completed
33 enrolled
Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XP
Phase 1/2 Completed
22 enrolled 11 charts
Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma
Phase 1/2 Completed
14 enrolled 16 charts
A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)
Phase 1/2 Completed
192 enrolled 24 charts
Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA
Phase 1/2 Completed
25 enrolled 17 charts
DEPICT
Phase 1/2 Completed
22 enrolled
Brentuximab Vedotin in Pre-transplant Induction and Consolidation for Relapsed or Refractory Hodgkin Lymphoma
Phase 1/2 Completed
67 enrolled
Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck
Phase 1/2 Completed
48 enrolled
Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer
Phase 1/2 Completed
55 enrolled 12 charts
Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
Phase 1/2 Completed
40 enrolled
Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer
Phase 1/2 Completed
63 enrolled
Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx
Phase 1/2 Completed
7 enrolled
Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium
Phase 1/2 Completed
15 enrolled
High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer
Phase 1/2 Completed
25 enrolled 7 charts
Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma
Phase 1/2 Completed
33 enrolled
PACT-19
Phase 1/2 Completed
137 enrolled
DAHANCA 28A: Phase I/II Study on Accelerated, Hyperfractionated Radiotherapy With Concomitant Cisplatin and Nimorazole
Phase 1/2 Completed
31 enrolled
Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC
Phase 1/2 Completed
73 enrolled
A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC)
Phase 1/2 Completed
27 enrolled 15 charts